Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07265557

A Pilot Randomized Controlled Trial Comparing Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients

Led by Massachusetts General Hospital · Updated on 2026-01-22

100

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

M

McMaster University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the feasibility of a larger study comparing two post-operative pain medication protocols at discharge for patients undergoing major orthopaedic surgery. This pilot randomized controlled trial aims to compare opioid-free discharge prescriptions to usual care that includes opioids. The study focuses on the design and feasibility of a definitive trial by assessing enrollment, adherence, and data collection metrics. Participants will be randomly assigned to receive either a discharge pain medication prescription without opioids or the usual care prescription that includes opioids. The specific medications, such as ibuprofen, paracetamol, ketorolac, or opioids, and their dosages are determined by the treating physician. The study plans to enroll at least 100 patients across various orthopaedic subspecialties including trauma, arthroplasty, foot and ankle, spine, and sports medicine. During the study, researchers will monitor feasibility from enrollment through a 6-week follow-up period. They will also compare opioid use and pain interference between the two groups. Patients will be assessed for opioid consumption and how pain affects their daily activities. This pilot trial helps prepare for a larger study while ensuring patient safety and data quality throughout the process.

CONDITIONS

Brief Title

Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years of age or older
  • Underwent a major operative orthopaedic procedure
Not Eligible

You will not qualify if you...

  • Contraindication for NSAIDs
  • Preoperative chronic opioid use (use of more than 14 days and average of more than 30 Morphine Milligram Equivalents per day)
  • Active treatment for opioid use disorder
  • Previous or current illicit drug use
  • Major surgery for cancer-related condition
  • Hand surgery
  • Concurrent operative treatment by another specialty team
  • Discharged to an extended medical care facility
  • Incarceration
  • Women who are pregnant or planning to become pregnant in the next 6 weeks
  • Expected injury survival of less than 6 weeks
  • Terminal illness with expected survival of less than 6 weeks
  • Anticipated problems with maintaining follow-up
  • Currently enrolled in a trial that does not permit co-enrollment
  • Prior enrollment in the trial
  • Unable to obtain informed consent
  • Non-English speaking
  • Eligible patient not approached prior to hospital discharge
  • Did not provide informed consent
  • Other reason to exclude the patient as approved by the Principal Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery and Immediate Post-operative Care

Duration - Hospital stay until discharge

Participants undergo major orthopaedic surgery and receive immediate post-operative care while hospitalized.

1 hospital stay

Treatment

Duration - From discharge until 6 weeks post-discharge

Participants are randomized to receive either a discharge pain medication prescription without opioids or usual care discharge pain medication with opioids as determined by their treating physician.

1 discharge visit and follow-up assessments up to 6 weeks

Follow-up

Duration - 6 weeks after discharge

Participants are followed for 6 weeks after discharge to monitor opioid use and pain interference.

Follow-up visits or assessments during 6 weeks post-discharge

Trial Site Locations

Total: 1 location

1

Mass

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

A

Arun Aneja, MD, PhD

S

Sheila Sprague, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Similar Trials

A Combined Treatment of Manual Therapy and Nervous Vagus Sti...

Temporomandibular Joint Disorders

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here